Xiangqian Kong

3.2k total citations
77 papers, 1.9k citations indexed

About

Xiangqian Kong is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiangqian Kong has authored 77 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Immunology. Recurrent topics in Xiangqian Kong's work include Epigenetics and DNA Methylation (14 papers), Genomics and Chromatin Dynamics (9 papers) and RNA modifications and cancer (9 papers). Xiangqian Kong is often cited by papers focused on Epigenetics and DNA Methylation (14 papers), Genomics and Chromatin Dynamics (9 papers) and RNA modifications and cancer (9 papers). Xiangqian Kong collaborates with scholars based in China, United States and Macao. Xiangqian Kong's co-authors include Cheng Luo, Hualiang Jiang, Junyan Lu, Zhongjie Liang, Sisheng Ouyang, Yong Wang, Shanjun Mao, Mingyue Zheng, Stephen B. Baylin and Yutong Gong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Xiangqian Kong

73 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangqian Kong China 24 1.2k 257 195 176 158 77 1.9k
Yew Mun Lee Singapore 20 825 0.7× 237 0.9× 197 1.0× 211 1.2× 93 0.6× 33 1.7k
Qiu Sun China 18 884 0.8× 245 1.0× 261 1.3× 234 1.3× 115 0.7× 60 1.6k
Jaspreet Kaur Dhanjal India 21 870 0.8× 311 1.2× 325 1.7× 318 1.8× 110 0.7× 57 2.1k
Xingyu Wang China 25 1.1k 0.9× 227 0.9× 104 0.5× 299 1.7× 176 1.1× 98 1.9k
Xing Du China 22 1.5k 1.3× 193 0.8× 278 1.4× 301 1.7× 166 1.1× 47 2.7k
Xuben Hou China 24 1.3k 1.1× 431 1.7× 325 1.7× 214 1.2× 207 1.3× 86 1.9k
Tulika Bhardwaj India 20 651 0.6× 326 1.3× 145 0.7× 118 0.7× 91 0.6× 74 1.3k
Xiaoli Xu China 28 1.5k 1.3× 448 1.7× 218 1.1× 247 1.4× 309 2.0× 87 2.1k
Wenqiang Cao China 27 789 0.7× 321 1.2× 428 2.2× 145 0.8× 460 2.9× 47 2.1k

Countries citing papers authored by Xiangqian Kong

Since Specialization
Citations

This map shows the geographic impact of Xiangqian Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangqian Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangqian Kong more than expected).

Fields of papers citing papers by Xiangqian Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangqian Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangqian Kong. The network helps show where Xiangqian Kong may publish in the future.

Co-authorship network of co-authors of Xiangqian Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangqian Kong. A scholar is included among the top collaborators of Xiangqian Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangqian Kong. Xiangqian Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Yuhui, Wen Chen, Li Zhan, et al.. (2025). Steroids with prominent cytotoxic activity against non-small cell lung cancer cells from the Strophanthus divaricatus. Fitoterapia. 182. 106447–106447.
2.
Wang, Jiongliang, Jiongliang Wang, Linfu Zhou, et al.. (2025). DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity. Science Immunology. 10(105). eadm8251–eadm8251. 3 indexed citations
3.
Kong, Xiangqian, et al.. (2024). Efficient Public-Key Searchable Encryption Scheme From PSI With Scalable Proxy Servers. IEEE Transactions on Services Computing. 17(6). 3527–3540. 1 indexed citations
4.
Wu, Kaixin, Sa Li, Guangliang Hong, et al.. (2024). Targeting METTL3 as a checkpoint to enhance T cells for tumour immunotherapy. Clinical and Translational Medicine. 14(11). e70089–e70089. 11 indexed citations
5.
Chen, Wei, et al.. (2024). Synthesis of STM2457, a selective small-molecule inhibitor of METTL3. Tetrahedron Letters. 141. 155077–155077. 2 indexed citations
6.
Wang, Huihui, et al.. (2024). Discovery of KW0113 as a First and Effective PROTAC Degrader of DNMT1 Protein. ChemMedChem. 19(24). e202400467–e202400467.
8.
Song, Jiaqi, et al.. (2023). Tinopanoids K-T, clerodane diterpenoids with anti-inflammatory activity from Tinospora crispa. Bioorganic Chemistry. 140. 106812–106812. 17 indexed citations
9.
Tao, Hongru, Xiao Li, Wenzhen Dang, et al.. (2023). PRMT1 Inhibition Activates the Interferon Pathway to Potentiate Antitumor Immunity and Enhance Checkpoint Blockade Efficacy in Melanoma. Cancer Research. 84(3). 419–433. 18 indexed citations
10.
Xia, Cuicui, et al.. (2023). Enhancing nicotinamide N-methyltransferase bisubstrate inhibitor activity through 7-deazaadenosine and linker modifications. Bioorganic Chemistry. 143. 106963–106963. 3 indexed citations
11.
Dong, Yongfei, et al.. (2021). SOCS1/JAK2/STAT3 axis regulates early brain injury induced by subarachnoid hemorrhage via inflammatory responses. Neural Regeneration Research. 16(12). 2453–2453. 23 indexed citations
12.
Kong, Xiangqian, et al.. (2018). Efficient hydrogenation of stearic acid over carbon coated Ni Fe catalyst. Journal of Catalysis. 367. 139–149. 76 indexed citations
13.
Cai, Yi, Hsing-Chen Tsai, Ray-Whay Chiu Yen, et al.. (2017). Critical threshold levels of DNA methyltransferase 1 are required to maintain DNA methylation across the genome in human cancer cells. Genome Research. 27(4). 533–544. 62 indexed citations
14.
Kong, Xiangqian, Jian Liu, Lianchun Li, et al.. (2015). Functional interplay between the RK motif and linker segment dictates Oct4–DNA recognition. Nucleic Acids Research. 43(9). 4381–4392. 16 indexed citations
15.
Li, Gang, et al.. (2015). Platelet endothelial cell adhesion molecule-1 gene 125C/G polymorphism is associated with deep vein thrombosis. Molecular Medicine Reports. 12(2). 2203–2210. 11 indexed citations
17.
Jiang, Baohong, Defang Li, Yanping Deng, et al.. (2013). Salvianolic Acid A, a Novel Matrix Metalloproteinase-9 Inhibitor, Prevents Cardiac Remodeling in Spontaneously Hypertensive Rats. PLoS ONE. 8(3). e59621–e59621. 62 indexed citations
18.
Chen, Xianjie, Jie Qin, Xiangqian Kong, et al.. (2013). Identification and synthesis of N-(thiophen-2-yl) benzamide derivatives as BRAFV600E inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(8). 2306–2312. 4 indexed citations
19.
Kong, Xiangqian, Hai Yuan, Xuejun Wu, et al.. (2012). High-mobility-group box protein 1 A box reduces development of sodium laurate-induced thromboangiitis obliterans in rats. Journal of Vascular Surgery. 57(1). 194–204. 15 indexed citations
20.
Liang, Zhongjie, Lianchun Li, Yuanyuan Wang, et al.. (2011). Molecular Basis of NDM-1, a New Antibiotic Resistance Determinant. PLoS ONE. 6(8). e23606–e23606. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026